RCT of BLT Implants Used for Immediate vs Early Placement, Restored With Ceramic Crowns on Titanium Bonding Bases.
BLT
Randomized Controlled Clinical Trial of BLT Implants Used for Immediate vs Early Placement and Restored With Lithium-disilicate Glass Ceramic or Sintered Zirconia Crowns on Titanium Bonding Bases.
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The purpose of this study is to assess the outcome of a new bone level tapered implant when inserted either following an immediate placement protocol or an early placement approach and restored with single crowns out of two different ceramic materials adhesively cemented on a titanium bonding base.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2015
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 5, 2015
CompletedFirst Submitted
Initial submission to the registry
March 17, 2021
CompletedFirst Posted
Study publicly available on registry
October 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2025
CompletedOctober 15, 2021
October 1, 2021
9.4 years
March 17, 2021
October 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Implant survival
Survival of the implant
5 years
Survival of the reconstructions
Survival of prosthetic reconstruction
5 years
Secondary Outcomes (5)
Mesial and distal bone levels
5 years
ISQ values
3 months
Soft tissue volume
5 years
Technical and biological outcomes of the restorations
5 years
Recording the need of GBR procedures
8 weeks
Study Arms (4)
Immediate implant placement
EXPERIMENTALImplant is placed immediately after tooth extraction.
Delayed implant placement
ACTIVE COMPARATORImplant is placed 8 weeks after tooth extraction.
Lithium disilicate crown
EXPERIMENTALCrown out of Lithiumdisilicate is inserted onto the implant.
Zirconia Crown
ACTIVE COMPARATORCrown out of Zirconia is inserted onto the implant.
Interventions
Implant surgery on different time points
Tooth restoration with a certain material
Eligibility Criteria
You may qualify if:
- Subjects must require extraction and replacement of a tooth in the maxillary or mandibular anterior or premolar region with an implant reconstruction.
- ≥22 years of age
- Patient in a good general health
- Adequate bone quality and quantity for one-stage implant placement
- Patient with physical status PS1 and PS2 (according to Physical Status Classification System of the American Society of Anesthesiologists; Attachment 5)
- Adequate bone height of at least 1mm longer than the length of the study implant
- Capable of providing written informed consent.
- Obtained informed consent from the patient and committed to the study and the required follow-up visits.
You may not qualify if:
- Patients with a high lip line / smile line
- Thin mucosal biotype
- Anatomically not sufficient bone volume or height at implant site to achieve primary stability of the implant
- Pronounced esthetic expectations
- Lack of keratinized mucosa at implant site (\< 2mm oral and buccal)
- Women of childbearing potential with a positive urine pregnancy test
- Patients with inadequate oral hygiene or persistent intraoral infection
- Smokers exceeding 10 cigarettes / day, or equivalent; patients chewing tobacco
- Severe bruxism or clenching habits
- Presence a systemic disease or allergy (e.g. conditions requiring chronic routine prophylactic use of antibiotics or prolonged use of steroids, history of rheumatic heart disease, bacterial endocarditis, cardiac vascular anomalies, prosthetic joint replacements, etc.)
- Presence or history of receiving intravenous or subcutaneous antiresorptive agents, such as bisphosphonates
- Presence of mucosal diseases (e.g. erosive lichen planus) in the localized area around the study implant
- Patients with history of renal failure, bleeding disorders, metabolic bone disorder, uncontrolled endocrine disorders, HIV infection, leucocyte dysfunction and deficiencies, neoplastic disease requiring the use of radiation or chemotherapy, etc.
- Patients with alcohol or drug abuse
- Participation in any other clinical trial (drug or device) less that 30 days before implant insertion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 17, 2021
First Posted
October 15, 2021
Study Start
October 5, 2015
Primary Completion
March 3, 2025
Study Completion
March 3, 2025
Last Updated
October 15, 2021
Record last verified: 2021-10